Fusion Antibodies PLC
LSE:FAB
Fusion Antibodies PLC
Free Cash Flow
Fusion Antibodies PLC
Free Cash Flow Peer Comparison
Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors
Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Fusion Antibodies PLC
LSE:FAB
|
Free Cash Flow
£-2.1m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Free Cash Flow
£-164.6m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
O
|
Open Orphan PLC
LSE:ORPH
|
Free Cash Flow
£14.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Diaceutics PLC
LSE:DXRX
|
Free Cash Flow
£226k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
|
Ergomed PLC
LSE:ERGO
|
Free Cash Flow
£16.8m
|
CAGR 3-Years
2%
|
CAGR 5-Years
71%
|
CAGR 10-Years
N/A
|
|
hVIVO PLC
LSE:HVO
|
Free Cash Flow
£20.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Fusion Antibodies PLC's Free Cash Flow?
Free Cash Flow
-2.1m
GBP
Based on the financial report for Sep 30, 2023, Fusion Antibodies PLC's Free Cash Flow amounts to -2.1m GBP.
What is Fusion Antibodies PLC's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-1%
Over the last year, the Free Cash Flow growth was -111%. The average annual Free Cash Flow growth rates for Fusion Antibodies PLC have been -46% over the past three years , -1% over the past five years .